Raphael Pharmaceutical Inc. (RAPH) Insider Trading

Name: Raphael Pharmaceutical Inc. (RAPH) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Apr 6, 2026): Louria Hayon Igal (Chief Technology Officer): In-the-Money Exercise of 350,000 shares, $3.5K.

Get alerted when insiders trade RAPH

Email address

Loading company data...

Beta

Loading company details...

Beta